DJ Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ slid 2.79% to $8.02 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.07% to 20,056.25 and the Dow Jones Industrial Average rising 0.16% to 44,627.59.
The stock's fall snapped a three-day winning streak.
Novavax Inc. closed 66.39% below its 52-week high of $23.86, which the company achieved on June 6th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ rose 1.87% to $157.89, Pfizer Inc. $(PFE)$ rose 1.29% to $25.89, and Merck & Co. Inc. $(MRK)$ rose 2.77% to $85.60.
Trading volume (3.6 M) remained 332,495 below its 50-day average volume of 3.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 19, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 19, 2025 17:31 ET (22:31 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。